InvestorsHub Logo
Followers 375
Posts 16966
Boards Moderated 4
Alias Born 03/07/2014

Re: NYC Trader post# 7546

Thursday, 04/17/2014 12:38:47 PM

Thursday, April 17, 2014 12:38:47 PM

Post# of 106837
" new study for DDD which will include a randomized control arm. The study has been reviewed and approved by the Institutional Review Board (IRB) of the International Cellular Medicine Society (ICMS). The ICMS IRB is committed to providing peer review of proposed studies of cell-based medical therapies based upon appropriate clinical translation, patient care and safety."

And blah, blah, blah, blah. MIRROR ANYONE? Hello? OR FDA, FDA, FDA. And what money will PAY FOR THIS "study"? And when, if ever, would any results ever be expected, let alone commercialization or monetization- what, "maybe" 5 to 10 yrs from now would be realistic per industry standards IMO?

WHO is the ole "International Cellular Medicine Society (ICMS)"???

Might want to check the recent FDA AUDIT they underwent and the subsequent findings and comments by the FDA regarding the "ICMS".

http://www.cellmedicinesociety.org/attachments/415_FDA%20483%20-%20ICMS%20IRB%20-%2019%20June%202012%20(redacted).pdf

http://www.cellmedicinesociety.org/home/boards-and-councils/414-fda-audit

http://www.cellmedicinesociety.org/home/boards-and-councils/415-fda-audit-findings

ALL my own opinions of course, no recommendation to buy, sell or hold any stock, or make anyone think or care about this particular company, or any company for that matter- just all my humble, 2 cent opinions from someone who is a total amateur stock trader/investor and knows nothing much about anything. Buy, sell or hold anything you want on your own- even comic book collectibles or Disney cartoon characters. It's all up to you and what you want to do- I only reflect on my own thoughts and own opinions and ideas and for my own self, not for anyone else.

Good luck and good trading/investing to all.